Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G

Journal of Virology

Volumn 74, Issue 8, 2000, Pages 3740-3751

  Jeeninga, Rienk E ^a   Hoogenkamp, Maarten ^a   Armand Ugon, Mercedes ^a   De Baar, Michel ^a   Verhoef, Koen ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLASMID DNA; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL TYPE; ENHANCER REGION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; VIRUS TYPING;

BASE SEQUENCE; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PHYLOGENY; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES; TATA BOX; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0034030611     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.8.3740-3751.2000     Document Type: Article

References (64)

1. Auersperg, N. 1964. Long-term cultivation of hypodiploid human tumor cells. J. Natl. Cancer Inst. 32:135-163.
2. Bell, B., and I. Sadowski. 1996. Ras-responsiveness of the HIV-1 LTR requires RBF-1 and RBF-2 binding sites. Oncogene 13:2687-2697.
3. Berkhout, B. 1992. Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis. Nucleic Acids Res. 20: 27-31.
4. Berkhout, B. 1996. Structure and function of the human immunodeficiency virus leader RNA. Progr. Nucleic Acid Res. Mol. Biol. 54:1-34.
5. Berkhout, B., and K. T. Jeang. 1991. Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains. Nucleic Acids Res. 19:6169-6176.
6. Berkhout, B., and K. T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
7. Berkhout, B., R. H. Silverman, and K. T. Jeang. 1989. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59: 273-282.
8. Berkhout, B., K. Verhoef, J. L. B. van Wamel, and N. K. T. Back. 1999. Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains. J. Virol. 73:1138-1145.
9. Carr, J. K., M. O. Salminen, J. Albert, E. Sanders-Buell, D. Gotte, D. L. Birx, and F. E. McCutchan. 1998. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology 247:22-31.
10. Carvalho, M., M. Kirkland, and D. Derse. 1993. Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity. J. Virol. 67:6586-6595.
11. Cornelissen, M., R. van den Burg, F. Zorgdrager, and J. Goudsmit. 2000. Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. J. Gen. Virol. 81:515-523.
12. Das, A. T., B. Klaver, and B. Berkhout. 1999. A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J. Virol. 73:81-91.
13. De Baar, M. P., A. De Ronde, B. Berkhout, M. Cornelissen, K. H. M. Van der Horn, A. M. Van der Schoot, F. De Wolf, V. V. Lukashov, and J. Goudsmit. 2000. Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer binding site. AIDS Res. Hum. Retrovir. 16:499-504.
14. Dingwall, C., I. Ernberg, M. J. Gait, S. M. Green, S. Heaphy, J. Karn, A. D. Lowe, M. Singh, M. A. Skinner, and R. Valerio. 1989. Human immunodeficiency Virus 1 tat protein binds trans-activating-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA 86:6925-6929.
15. Dittmar, M. T., G. Simmons, S. Hibbitts, M. O'Hare, S. Louisrirotchanakul, S. Beddows, J. Weber, P. R. Clapham, and R. A. Weiss. 1997. Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J. Virol. 71:8008-8013.
16. Estable, M. C., B. Bell, M. Hirst, and I. Sadowski. 1998. Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription. J. Virol. 72:6465-6474.
17. Fauci, A. S., and R. C. Desrosiers. 1997. Pathogenesis of HIV and SIV, p. 587-636. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
18. Gao, F., E. Bailes, D. L. Robertson, Y. Chen, C. M. Rodenburg, S. F. Michael, L. B. Cummins, L. O. Arthur, M. Peeters, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436-441.
19. Gao, F., D. L. Robertson, C. D. Carruthers, Y. Li, E. Bailes, L. G. Kostrikis, M. O. Salminen, F. Bibollet-Ruche, M. Peeters, D. D. Ho, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1998. An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I). J. Virol. 72:10234-10241.
20. Gao, F., D. L. Robertson, C. D. Carruthers, S. G. Morrison, B. Jian, Y. Chen, F. Barre-Sinoussi, M. Girard, A. Srinivasan, A. G. Abimiku, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1998. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J. Virol. 72:5680-5698.
21. Gaynor, R. B. 1995. Regulation of HIV-1 gene expression by the transactivator protein Tat. Curr. Top. Microbiol. Immunol. 193:51-77.
22. Giacca, M., M. I. Gutierrez, S. Menzo, F. D'adda di Fabrizio, and A. Falaschi. 1992. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. Virology 186:133-147.
23. Grez, M., M. Zörnig, J. Nowock, and M. Ziegler. 1991. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells. J. Virol. 65:4691-4698.
24. Heinemeyer, T., E. Wingender, I. Reuter, H. Hermjakob, A. E. Kel, O. V. Kel, E. V. Ignatieva, E. A. Ananko, O. A. Podkolodnaya, F. A. Kolpakov, N. L. Podkolodny, and N. A. Kolchanov. 1998. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26:362-367.
25. Huang, L. M., and K. T. Jeang. 1993. Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function. J. Virol. 67:6937-6944.
26. Klasens, B. I., H. T. Huthoff, A. T. Das, R. E. Jeeninga, and B. Berkhout. 1999. The effect of template RNA structure on elongation by HIV-1 reverse transcriptase. Biochim. Biophys. Acta 1444:355-370.
27. Klaver, B., and B. Berkhout. 1994. Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus. J. Virol. 68: 3830-3840.
28. Koken, S. E. C., J. L. van Wamel, J. Goudsmit, B. Berkhout, and J. L. Geelen. 1992. Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 191:968-972.
29. Leitman, D. C., E. R. Mackow, T. Williams, J. D. Baxter, and B. L. West. 1992. The core promoter region of the tumor necrosis factor alpha gene confers phorbol ester responsiveness to upstream transcriptional activators. Mol. Cell. Biol. 12:1352-1356.
30. Lole, K. S., R. C. Bollinger, R. S. Paranjape, D. Gadkari, S. S. Kulkarni, N. G. Novak, R. Ingersoll, H. W. Sheppard, and S. C. Ray. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73:152-160.
31. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
32. Markovitz, D. M. 1993. Infection with human immunodeficiency virus type 2. Ann. Intern. Med. 118:211-218.
33. Maury, W. 1998. Regulation of equine infectious anemia virus expression. J. Biomed. Sci. 5:11-23.
34. McKeating, J. A., A. McKnight, and J. P. Moore. 1991. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J. Virol. 65:852-860.
35. Melkonyan, H., C. Sorg, and M. Klempt. 1996. Electroporation efficiency in mammalian cells is increased by dimethyl sulfoxide (DMSO). Nucleic Acids Res. 24:4356-4357.
36. Montano, M. A., C. P. Nixon, and M. Essex. 1998. Dysregulation through the NF-KB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter. J. Virol. 72:8446-8452.
37. Montano, M. A., V. A. Novitsky, J. T. Blackard, N. L. Cho, D. A. Katzenstein, and M. Essex. 1997. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J. Virol. 71:8657-8665.
38. Moore, J. P., J. A. McKeating, R. A. Weiss, and Q. J. Sattentau. 1990. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250:1139-1142.
39. Mummaneni, P., P. Yates, J. Simpson, J. Rose, and M. S. Turker. 1998. The primary function of a redundant SpI binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation. Nucleic Acids Res. 26: 5163-5169.
40. Myers, G., B. Korber, B. H. Hahn, K.-T. Jeang, J. H. Mellors, F. E. McCutchan, L. E. Henderson, and G. N. Pavlakis. 1995. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.Mex.
41. Naghavi, M. H., S. Schwartz, A. Sonnerborg, and A. Vahlne. 1999. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res. Hum. Retrovir. 15:1293-1303.
42. Olsen, H. S., and C. A. Rosen. 1992. Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J. Virol. 66:5594-5597.
43. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86: 2336-2340.
44. ELJ. Virology 185: 661-672.
45. Pepin, J., G. Morgan, D. Dunn, S. Gevao, M. Mendy, I. Gaye, N. Scollen, R. Tedder, and H. Whittle. 1991. HIV-2-induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS 5:1165-1172.
46. Pope, M., S. S. Frankel, J. R. Mascola, A. Trkola, F. Isdell, D. L. Birx, D. S. Burke, D. D. Ho, and J. P. Moore. 1997. Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism. J. Virol. 71:8001-8007.
47. Pugh, B. F. 1996. Mechanisms of transcription complex assembly. Curr. Opin. Cell Biol. 8:303-311.
48. Robertson, D. L., B. H. Hahn, and P. M. Sharp. 1995. Recombination in AIDS viruses. J. Mol. Evol. 40:249-259.
49. Roeder, R. G. 1996. The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem. Sci. 21:327-335.
50. Ross, E. K., A. J. Buckler-White, A. B. Rabson, G. Englund, and M. A. Martin. 1991. Contribution of NF-KB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J. Virol. 65:4350-4358.
51. Rousseau, C., E. Abrams, M. Lee, R. Urbano, and M.-C. King. 1997. Long terminal repeat and nef gene variants of human immunodeficiency virus type 1 in perinatally infected long-term survivors and rapid progressors. AIDS Res. Hum. Retrovir. 13:1611-1623.
52. Selby, M. J., E. S. Bain, P. A. Luciw, and B. M. Peterlin. 1989. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 3: 547-558.
53. Sieweke, M. H., H. Tekotte, U. Jarosch, and T. Graf. 1998. Cooperative interaction of Ets-1 with USF-1 required for HIV-1 enhancer activity in T cells. EMBO J. 17:1728-1739.
54. Simon, F., P. Mauclere, P. Roques, I. Loussert-Ajaka, M. C. Muller-Trutwin, S. Saragosti, M. C. Georges-Courbot, F. Barre-Sinoussi, and F. Brun-Vezinet. 1998. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 4:1032-1037.
55. Smith, S. D., M. Shatsky, P. S. Cohen, R. Warnke, M. P. Link, and B. E. Glader. 1984. Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res. 44:5657-5662.
56. Soto-Ramirez, L. E., B. Renjifo, M. F. McLane, R. Marlink, C. O'Hara, R. Sutthent, C. Wasi, P. Vithayasai, V. Vithayasai, C. Apichartpiyakul, P. Auewarakul, V. Pena Cruz, D. S. Chui, R. Osathanondh, K. Mayer, T. H. Lee, and M. Essex. 1996. HIV-1 Langerhans cell tropism associated with heterosexual transmission of HIV. Science 271:1291-1293.
57. Takehisa, J., L. Zekeng, E. Ido, Y. Yamaguchi-Kabata, I. Mboudjeka, Y. Harada, T. Miura, L. Kaptué, and M. Hayami. 1999. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J. Virol. 73:6810-6820.
58. Tsichlis, P. N., and P. A. Lazo. 1991. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses, p. 95-171. In H. J. Kung and P. K. Vogt (ed.), Retroviral insertion and oncogene activation. Springer-Verlag, Berlin, Germany.
59. Van de Peer, Y., and R. De Wachter. 1997. Construction of evolutionary distance trees with TREECON for Windows: accounting for variation in nucleotide substitution rate among sites. Comput. Appl. Biosci. 13:227-230.
60. Van Lint, C., C. A. Amella, S. Emiliani, M. John, T. Jie, and E. Verdin. 1997. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol. 71:6113-6127.
61. Verhoef, K., M. Koper, and B. Berkhout. 1997. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology 237:228-236.
62. Verhoef, K., R. W. Sanders, V. Fontaine, S. Kitajima, and B. Berkhout. 1999. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-KB enhancer element into a GABP hinding site. J. Virol. 73:1331-1340.
63. Wain-Hobson, S. 1998. More ado about HIV's origins. Nat. Med. 4:1001-1002.
64. Wei, P., M. E. Garber, S.-M. Fang, W. H. Fisher, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.